These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34343139)

  • 1. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis.
    Guillot SJ; Bolborea M; Dupuis L
    Curr Opin Neurol; 2021 Oct; 34(5):773-780. PubMed ID: 34343139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal energy metabolism in ALS: a key player?
    Burg T; Van Den Bosch L
    Curr Opin Neurol; 2023 Aug; 36(4):338-345. PubMed ID: 37338894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.
    Nelson AT; Trotti D
    Neurotherapeutics; 2022 Jul; 19(4):1102-1118. PubMed ID: 35773551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
    Perera ND; Turner BJ
    Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.
    Ioannides ZA; Ngo ST; Henderson RD; McCombe PA; Steyn FJ
    Neurodegener Dis; 2016; 16(5-6):382-97. PubMed ID: 27400276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.
    Maksimovic K; Youssef M; You J; Sung HK; Park J
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis.
    Giagnorio E; Malacarne C; Mantegazza R; Bonanno S; Marcuzzo S
    J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34137441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.
    Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.
    Benson BC; Shaw PJ; Azzouz M; Highley JR; Hautbergue GM
    Front Neurosci; 2021; 15():783624. PubMed ID: 35002606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
    Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
    Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis.
    Lim MA; Bence KK; Sandesara I; Andreux P; Auwerx J; Ishibashi J; Seale P; Kalb RG
    Hum Mol Genet; 2014 Sep; 23(18):4995-5008. PubMed ID: 24833719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in ALS: an underappreciated opportunity?
    Vandoorne T; De Bock K; Van Den Bosch L
    Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
    Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
    Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis.
    Wang Y; Yi H; Liao Q; Bi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1483-1489. PubMed ID: 33473007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
    Rinchetti P; Rizzuti M; Faravelli I; Corti S
    Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium Dyshomeostasis and Lysosomal Ca
    Tedeschi V; Petrozziello T; Secondo A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional and metabolic factors in amyotrophic lateral sclerosis.
    Ludolph A; Dupuis L; Kasarskis E; Steyn F; Ngo S; McDermott C
    Nat Rev Neurol; 2023 Sep; 19(9):511-524. PubMed ID: 37500993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
    Tefera TW; Steyn FJ; Ngo ST; Borges K
    Cell Biosci; 2021 Jan; 11(1):14. PubMed ID: 33431046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy metabolism in amyotrophic lateral sclerosis.
    Dupuis L; Pradat PF; Ludolph AC; Loeffler JP
    Lancet Neurol; 2011 Jan; 10(1):75-82. PubMed ID: 21035400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.